Atlas Trials

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Clinical trial NCT01545141 · TERMINATED

Trial details

NCT number
NCT01545141
Sponsor
Roswell Park Cancer Institute
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Colorectal CancerColorectal CarcinomaColorectal TumorsNeoplasms, Colorectal
Start date
2012-10-01
Primary completion
2016-04-08
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.